Löwenstein Sleep Devices

Santé are committed to providing sustainable & professional solutions to the valued sleep professional fraternity & are bringing the Löwenstein range of sleep therapy products to Australia. Löwenstein are a premium respiratory device manufacturer in Germany, having developed leading edge technology in healthcare & homecare breathing support.

Together, we are ensuring:

  • Unsurpassed quality
  • Proven clinical efficacy
  • Sustainable business outcomes
  • Guaranteed support & servicing

Products we provide

What does successful sleep therapy look like?

There is no set formula for the successful treatment of sleep disordered breathing (i.e. obstructive sleep apnoea). The treatment process is a complex matter & intensely individual, when it comes to PAP therapy, a practical test & trial process fine-tuned & tailored to an individual’s experience & needs by a trained professional is the consistent way to optimise the treatment outcome.

When asked what defines successful sleep apnoea treatment, the usual metric clinicians & specialists refer to is AHI (Apnoea Hypopnea Index) per hour. A score of less than 5 AHI/hr is the typical theoretical definition of clinical effectiveness in PAP therapy. In reality, therapy outcome revolves around more than AHI/hr. The following chart offers insight into how Santé & Löwenstein view therapy success.

The Löwenstein Difference

The Löwenstein devices consistently demonstrate clinical efficacy (AHI<5/hour), with further key clinical features as follows:

  • Prisma RECOVER: Innovative feature that estimates deep sleep.
  • High accuracy of AHI detection: 96% accuracy level with PG as reference.
  • Adaptive algorithm regulation: epoch-based response is needs-sensitive, dynamically regulating dependant on position in the pressure range.
  • Dynamic & Standard Algorithm: 2 settings to suit different patients & stage of treatment.
  • Stability of pressure adjustment: therapeutically effective with no unnecessary fluctuation.
  • Efficiency of pressure: consistently low Pmax & Pmean.
  • Pressure relief SoftPAP: no compromise on clinical outcome.